dc.contributor.author | Kiwanuka, Julius P | |
dc.contributor.author | Mwanga, Juliet | |
dc.date.accessioned | 2022-05-09T08:18:52Z | |
dc.date.available | 2022-05-09T08:18:52Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Kiwanuka, J. P., & Mwanga, J. (2001). Childhood bacterial meningitis in Mbarara Hospital, Uganda: antimicrobial susceptibility and outcome of treatment. African health sciences, 1(1), 9-11. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/1858 | |
dc.description.abstract | Background: The recommended antibiotic treatment of bacterial meningitis has come under scrutiny following frequent reports of in-vitro resistance by the common causative organisms to penicillin and chloramphenicol.
Objective: The study recorded the causative organisms, antibiotic sensitivity patterns and outcome of treatment of bacterial meningitis in children and examined the impact of various factors on the recorded outcome.
Design: This was a retrospective review of all case records of patients treated for bacterial meningitis over a one-year period.
Setting: The study was set in the Paediatric wards of Mbarara University Teaching Hospital, in south western Uganda.
Results: A total of 77 patients were treated. Among 56 patients with available CSF results the frequency of bacterial causes was as follows: H. influenzae 13(23.2%), coliforms 7(12.5%), uncultured Gram-negative bacilli 7(12.5%), S. pneumoniae 5(8.9%) and N. meningitidis 3(5.4%). Most Isolates tested were resistant to both penicillin and chloramphenicol, but all were sensitive to ciprofloxacin and perfloxacln. Twenty eight (36.8%) patients di@ (:l,22(28.9%) survived with sequelae and 15(19.7%) improved without sequelae. 14/18 who received perfloxacin and/or ciprofloxacin survived compared with 23/47 who did not: p=0.04).
Conclusions: The high case-fatality rates and the high frequency of resistance to penicillin and chloramphenicol make a case for a review of the currently recommended antibiotic treatment of bacterial meningitis in this region. Fluoroquinolones need further evaluation as potential alternatives to chloramphenicol in the treatment of bacterial meningitis. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | African Health Sciences | en_US |
dc.subject | Childhood bacterial meningitis | en_US |
dc.subject | Antimicrobial susceptibility | en_US |
dc.subject | Treatment outcome | en_US |
dc.title | Childhood bacterial meningitis in Mbarara Hospital, Uganda: antimicrobial susceptibility and outcome of treatment. | en_US |
dc.type | Article | en_US |